Trandate 100mg 56’s features Labetalol, a dual-action alpha- and beta-adrenergic blocker, designed to effectively manage high blood pressure. This medication works by relaxing blood vessels and slowing the heart rate, which reduces blood pressure and the heart’s workload.
It is particularly effective in managing moderate to severe hypertension, hypertensive crises, and pregnancy-related high blood pressure (preeclampsia). Its balanced action on both alpha and beta receptors provides a comprehensive approach to lowering blood pressure, helping prevent complications such as stroke, heart attack, or kidney damage.
Key Benefits:
- Comprehensive Blood Pressure Control: Reduces heart rate and relaxes blood vessels for effective hypertension management.
- Pregnancy-Safe: Commonly prescribed to manage high blood pressure during pregnancy under medical supervision.
- Fast-Acting: Useful in hypertensive emergencies and crises for rapid blood pressure reduction.
- Cardiovascular Protection: Lowers the risk of hypertension-related complications like heart attacks or strokes.
Dosage and Administration:
- Usual Dose: The starting dose is typically 100mg twice daily. Your doctor may adjust the dosage based on your response and health needs.
- Administration: Take the tablet with water, with or without food, at the same time each day.
Precautions:
- Not Suitable for Asthma: Avoid use in patients with asthma or chronic obstructive pulmonary disease (COPD).
- Liver Conditions: Use cautiously in patients with liver impairment.
- Pregnancy and Breastfeeding: Consult your doctor before using this medication during pregnancy or breastfeeding.
- Dizziness and Drowsiness: May cause dizziness, especially when starting the medication. Avoid driving or operating machinery until you are familiar with its effects.
Possible Side Effects:
- Common: Dizziness, fatigue, nausea, headache.
- Rare: Allergic reactions, slow heart rate, liver function changes. Seek medical attention if you experience severe side effects.
Reviews
There are no reviews yet.